Buradasınız

Anasayfa » Content

BÖBREK NAKLİ SONRASINDA CsA KULLANAN HASTALARDA DİŞETİ BÜYÜMESİNİN GÖRÜLME SIKLIĞI

PREVALENCE OF GINGIVAL HYPERPLASIA IND UCED BY CYCLOSPORINE - A IN RENAL TRANSPLANTS

Journal Name:

  • İstanbul Üniversitesi Diş Hekimliği Fakültesi Dergisi

Publication Year:

  • 1995

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
CYCLOSPORINE-A is a potent immunosuppresive compound that has been used in conjunction with organ transplants. Renal transplant patients are usually medicated with Üıe combination of Azathîoprine and Cortisone in addition to cyclosporin. There are numerous adverse side effects of cyclosporine. Side effects include lymphoma, nephrotoxicity, hepatotoxicity and gingival hyperplasia. In this investigation 69 renal transplant patients who are periodically controlled at the Ege University Medical Center have been included. Upper and lower 6 anterior teeth and both buccal and lingual gingival papillas of these teeth are used in examination. The determination included plaque scores (PII), probing deptlis, papilla bleeding index (PBI) and hyperplastic index (HI). Patients whole blood CsA concentrations are standardized as morning values oj blood tests. The mean scores of clinical parameters (mean S.E) in the patients were, probing depth= 1.73±0.72, PII« 2.94 ± 0.92, PBI= 1.19 ± 0.66. Gingival hyperplasia were determined in 71 % of the patients. Results of clinical studies and laboratory values are evaluated statistically.
Bookmark/Search this post with
Abstract (Original Language): 
Organ reddini önlemek için, organ naklinden sonraki dönemde kullanılan immunsüpresif ilaçlardan birisi de siklosporin A (CsA)'dır. Bu hasta grubunda uygulanan kombine ilaç tedavisinde yer alan Azathioprİne ve Kortizon da kullanılan diğer immunsüpresif ilaçlardır. Kullanılan CsA; nefrotoksisite, hepatotoksisite, lenfo-ma ve dişeti büyümesi gibi yan etkileri sahiptir. Araştırmamıza, böbrek nakli yapılmış ve E,Ü. Tıp Fa-kültesi'de rutin kontrolleri yapılan 69 hasta dahil edilmiştir. Hastaların, alt-üst ön bölgedeki 6 kesici dişleri ve bu dişlerin dudak ve dil tarafındaki dişeti papilaları değerlendirilmiştir. Değerlendirmede cep derinliği, Plak İndeks (Pil), Papila Kanama İndeks <PBI) ve Hi-peı-plazi İndeksi (HI) kullanılmıştır. Hastaların CsA serum seviyeleri, sabah alman kanda tayin edilmiştir. Çeşitli sürelerde CsA kullanan hastaların ortalama cep derinliği =1.73±0.72, ort. PII= 2.94 ± 0.92, ort. PBI= 1.19 ± 0.66 dır. değerlendirilen hastaların % 71 de çeşitli seviyelerde dişeti büyümesi saptanmıştır. Ayrıca, hastalardan elde edilen klinik ve laboratuvar parametrelerin dişeti büyümesi ile ilişkisi istatistiksel olarak değerlendirilmiştir. Ülkemiz insanlarının genelde iyi olduğu söylenemeye» ağız bakımlarının varlığında, adı geçen ilacın dişeü büyümesi açısından etkisini araştırmak ve bu konuda var olan sınırlı sayıdaki araştırma verilerine verilerimizi ilave etmek amacımızı oluşturmuştur.
FULL TEXT (PDF): 
PDF icon arastirmax-bobrek-nakli-sonrasinda-csa-kullanan-hastalarda-diseti-buyumesinin-gorulme-sikligi.pdf
  • 1
65
70
  • Turkish

REFERENCES

References: 

1. Bennet, JA, & Christian, JM : Cyclosporin-induced gingival hyperplasia: Case report and literature review 1985: 111: 433-7.
2. Bowman, JM, Levy, BA, Grubb, RV : Gingival overgrowth induced by diltiazem. Oral Surg 1988: 65:183-5.
3. Daley, TD, Wysocki, GP, Colin, D.: Clinical and pharmacologic correletions in cyclosporine - induced gingival hyperplasia. Oral Surg Oral Med Oral Pathol 1986: 62:417-21.
4. Friskopp, J & Klintmalm, G : Gingival enlargement. A comparison between cyclosporine and azathioprine treated renal allograft recipients. Swedish DentalJ1986:10: 85-92.
5. Hassel, TM, Buchanan, J Cuchens, M, Douglas, R : Fluorescence activated vital cell sorting of human fibroblasts subpopulations that bind cyclosporine -A. J Dent Res 1988 (abstr.l285):2772.
6. Hassel, T : Epilepsy and the oral manifestations of phenytoin therapy Basel, Switzerland: S Karer, 1981.
7. King, GN, Fullinfaw, R, Higgins, TJ, Walker, RG, Francis, DMA, Wiesenfeld, D : Gingival hyperplasia in renal allograft recipients receiving cyclosporin-A and calcium antagonists./ Clin Periodontol 1993: 20:286-93.
8. Lederman, D, Lumerman, H, Reuben, S, Frcedman, PD: Gingival hyperplasia associated with nifedipine therapy. Oral Surg 1984: 57:620-2.
9. Lemaire, M, Maurer, G, Wood, AJ : Pharmacokinetics and metabolism. Prog Allergy 1986: 38: 93-107.
10. McGraw, T, Lam, S, Coates, J : Cyclosporin-induced gingival overgrowthxorrelation with dental plaque scores, gingivitis scores and cyclosporin levels in serum and saliva. Oral Surg 1987: 64:293-7.
11. Nishikawa, S, Tada, H, Hamasaki, A, et al: Nifedipi-ne-induced gingival hyperplasia: A clinical and iin vitro study. J Periodontol 1991: 62: 30-5.
12. Pemu, HE, Pemu, LMH, Huttunen, KRH, Nieminen, PA, Knuutila, MLE : Gingival overgrowth among renal transplant recipients related to immunosuppressive medication and possible local background factors. / Periodontol 1992: 63:548-53.
13. Quigley, GA, Hein, JW: Comporotive vleansing efficiency of manual and power brushing, JADA 1962: 65:26-9.
14. Rateitschak-Pluss, EE, Hefti, A, Lırtscher, R, Theil, G : Initial observations that A induces gingival enlargement in man./Clin Periodontol 1983:10: 237-246.
15. Rostock, MH, Fry, HR, Turner, JE : Severe gingival overgrowth associated with cyclosporine therapy. J Periodontol 1986: 57:294-9.
16. Saxer, UP, Mühlemann, HR: Motivation und aufkla-rung. Schweiz Mschr Zahnheilk 1973: 55: 905-19.
17. Seymour, RA, Smith, DG:The effect of a plaque control programme on theincidence and severity of cyclosporin-induced gnigtval changes./Clin Periodontol 1991: 18:107¬10.
18. Seymour, RA,Smith, DG, Rogers, SR: The comparative effects of azathioprine and cyclosporin on some gingival health parameterks of renal transplant patients. A longitudinal study./ Clin Periodontol 1987: 14:610-3.
19. Seymour, RA, Smith, DG, Tumbull, DN : The effects of phenytoin and sodium valporate on the periodontal health of adult epileptic patients./ Clin Periodontol 1985: 12: 413-9.
20. Shaw, LM,: Advances in cyclosporine pharmacology, measurement, and therapeutic nomitoring. Clin Chem 1989: 35: 1299-1308.
21. Slavin, J, & Taylor, J : Cyclosporin, nifedipine, and gingival hyperplasia. Lancet 1987: 2: 739.
22. Thiel, G, Landman, J, Mihatsc, MJ : Optimal use of Sandimmun in renal transplantation: The Basel experiece. In: Land, W, ed Optimal Used of Sandimmun in Organ Transplatation. Berlin: Springer Verlag, 1987: 25-7.
23. ThomasonJM, Seymour, RA, Rice, N : The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth./amPmodoHto/1993: 157: 305-9.
24. Tyldesley, WR, & Rotter, E : Gingival hyperplasia induced by cyclosporin-A Br Denf/1984: 157: 305-9.
25. Wysocki, GP, Gretzinger, HA, Laupacis, A. Ulan, RA, Stiller, CR : Fibrous hyperplasia of the gingiva side effect of cyclosporine A therapy. Oral Surg 1983:55: 274-8.

Thank you for copying data from http://www.arastirmax.com